HomeSABS • NASDAQ
add
SAB Biotherapeutics Inc
Previous close
$3.07
Day range
$3.00 - $3.22
Year range
$2.18 - $9.72
Market cap
28.89M USD
Avg Volume
123.51K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.48M | 35.33% |
Net income | -10.35M | -102.84% |
Net profit margin | — | — |
Earnings per share | -1.12 | -10.99% |
EBITDA | -10.36M | -137.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 30.40M | 1,153.39% |
Total assets | 53.80M | 89.85% |
Total liabilities | 16.89M | 29.16% |
Total equity | 36.90M | — |
Shares outstanding | 9.23M | — |
Price to book | 0.77 | — |
Return on assets | -48.88% | — |
Return on capital | -60.88% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -10.35M | -102.84% |
Cash from operations | -6.29M | -21.75% |
Cash from investing | -1.15M | -2,721.23% |
Cash from financing | -674.13K | -380.46% |
Net change in cash | -8.07M | -50.89% |
Free cash flow | -3.13M | 10.92% |
About
Founded
2014
Headquarters
Website
Employees
57
